Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
Precision BioSciences is a clinical-stage biotechnology company specializing in in vivo gene editing therapies using its proprietary ARCUS platform. The platform employs engineered nucleases derived from natural homing endonucleases to develop precise, safe, and durable genetic treatments. The company focuses on therapies for infectious and genetic diseases, leveraging its innovative technology to create targeted, potentially curative solutions across multiple tissue types and conditions.
This description was generated via AI from an annual report. Updated about 1 year ago.